» Articles » PMID: 25797279

The Expression of Neurogenic Markers After Neuronal Induction of Chorion-derived Mesenchymal Stromal Cells

Overview
Journal Neurol Res
Specialty Neurology
Date 2015 Mar 24
PMID 25797279
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Chorion is a tissue of early embryologic period that is discarded after delivery. It might be the potential source of mesenchymal stromal cells (MSCs) that can be used for research and eventually for therapeutic studies. At present, the biological properties and the differentiation capacity of chorion-derived MSCs are still poorly characterised. The objective of this study is to characterise and explore the differentiating potential of chorion-derived MSCs towards the neuronal lineages.

Methods: Chorionic membrane was digested with enzyme and cultured in Dulbecco's Modified Eagle's medium supplemented with 10% fetal bovine serum. The expression of MSC markers was examined using flow cytometry. The adipogenic, osteogenic and neurogenic differentiation were examined by culturing in appropriate induction media. The expression of neuronal markers was determined by immunofluorescence and quantitative real time-PCR.

Results: Chorion-derived MSCs were easily expanded up to 20 passages. They were positive for MSC markers (CD73, CD90 and CD105), and negative for haematopoietic markers (CD34 and CD45). Chorion-derived MSCs could differentiate into several mesodermal-lineages including adipocytes and osteoblasts. Moreover, chorion-derived MSCs could differentiate into neuronal-like cells as characterised by cell morphology and the presence of neural markers including MAP-2, glial fibrillary acidic protein (GFAP) and beta-tubulin III.

Discussion: Chorion-derived MSCs can be readily obtained and expanded in culture. These cells also have transdifferentiation capacity as evidenced by their neuronal differentiation potential. Therefore, chorion can be used as an alternative source of MSCs for stem cell therapy in nervous system disorders.

Citing Articles

Fucoxanthin diminishes oxidative stress damage in human placenta-derived mesenchymal stem cells through the PI3K/Akt/Nrf-2 pathway.

Suwanmanee G, Tantrawatpan C, Kheolamai P, Paraoan L, Manochantr S Sci Rep. 2023; 13(1):22974.

PMID: 38151503 PMC: 10752906. DOI: 10.1038/s41598-023-49751-5.


Role of YAP as a Mechanosensing Molecule in Stem Cells and Stem Cell-Derived Hematopoietic Cells.

Damkham N, Issaragrisil S, Lorthongpanich C Int J Mol Sci. 2022; 23(23).

PMID: 36498961 PMC: 9737411. DOI: 10.3390/ijms232314634.


Fisetin Inhibits Osteogenic Differentiation of Mesenchymal Stem Cells via the Inhibition of YAP.

Lorthongpanich C, Charoenwongpaiboon T, Supakun P, Klaewkla M, Kheolamai P, Issaragrisil S Antioxidants (Basel). 2021; 10(6).

PMID: 34070903 PMC: 8226865. DOI: 10.3390/antiox10060879.


MicroRNA treatment modulates osteogenic differentiation potential of mesenchymal stem cells derived from human chorion and placenta.

Marupanthorn K, Tantrawatpan C, Kheolamai P, Tantikanlayaporn D, Manochantr S Sci Rep. 2021; 11(1):7670.

PMID: 33828198 PMC: 8027176. DOI: 10.1038/s41598-021-87298-5.


Mesenchymal stromal cells' role in tumor microenvironment: involvement of signaling pathways.

Nwabo Kamdje A, Takam Kamga P, Tagne Simo R, Vecchio L, Seke Etet P, Muller J Cancer Biol Med. 2017; 14(2):129-141.

PMID: 28607804 PMC: 5444925. DOI: 10.20892/j.issn.2095-3941.2016.0033.